IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 336 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,680 | +10.6% | 500 | 0.0% | 0.01% | +14.3% |
| Q2 2023 | $20,515 | +14.8% | 500 | 0.0% | 0.01% | 0.0% |
| Q1 2023 | $17,870 | -5.4% | 500 | 0.0% | 0.01% | -12.5% |
| Q4 2022 | $18,885 | -57.1% | 500 | -49.8% | 0.01% | -52.9% |
| Q3 2022 | $44,000 | +18.9% | 997 | 0.0% | 0.02% | +13.3% |
| Q2 2022 | $37,000 | 0.0% | 997 | 0.0% | 0.02% | +36.4% |
| Q1 2022 | $37,000 | +23.3% | 997 | 0.0% | 0.01% | +37.5% |
| Q4 2021 | $30,000 | -9.1% | 997 | 0.0% | 0.01% | -20.0% |
| Q3 2021 | $33,000 | -17.5% | 997 | -0.3% | 0.01% | -9.1% |
| Q2 2021 | $40,000 | -11.1% | 1,000 | 0.0% | 0.01% | -21.4% |
| Q1 2021 | $45,000 | -21.1% | 1,000 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $57,000 | -65.7% | 1,000 | -81.5% | 0.02% | -74.3% |
| Q3 2020 | $166,000 | +186.2% | 5,400 | +440.0% | 0.07% | +191.7% |
| Q2 2020 | $58,000 | +23.4% | 1,000 | 0.0% | 0.02% | -20.0% |
| Q1 2020 | $47,000 | -21.7% | 1,000 | 0.0% | 0.03% | +25.0% |
| Q4 2019 | $60,000 | +1.7% | 1,000 | 0.0% | 0.02% | -20.0% |
| Q3 2019 | $59,000 | -7.8% | 1,000 | 0.0% | 0.03% | -16.7% |
| Q2 2019 | $64,000 | -21.0% | 1,000 | 0.0% | 0.04% | -34.5% |
| Q1 2019 | $81,000 | +50.0% | 1,000 | 0.0% | 0.06% | +41.0% |
| Q4 2018 | $54,000 | +5.9% | 1,000 | 0.0% | 0.04% | +56.0% |
| Q3 2018 | $51,000 | +21.4% | 1,000 | 0.0% | 0.02% | +38.9% |
| Q2 2018 | $42,000 | -4.5% | 1,000 | 0.0% | 0.02% | 0.0% |
| Q1 2018 | $44,000 | -12.0% | 1,000 | 0.0% | 0.02% | -10.0% |
| Q4 2017 | $50,000 | -2.0% | 1,000 | 0.0% | 0.02% | -13.0% |
| Q3 2017 | $51,000 | 0.0% | 1,000 | 0.0% | 0.02% | 0.0% |
| Q2 2017 | $51,000 | +27.5% | 1,000 | 0.0% | 0.02% | +15.0% |
| Q1 2017 | $40,000 | -16.7% | 1,000 | 0.0% | 0.02% | -16.7% |
| Q4 2016 | $48,000 | +29.7% | 1,000 | 0.0% | 0.02% | +26.3% |
| Q3 2016 | $37,000 | +60.9% | 1,000 | 0.0% | 0.02% | +58.3% |
| Q2 2016 | $23,000 | -43.9% | 1,000 | 0.0% | 0.01% | -58.6% |
| Q1 2016 | $41,000 | -33.9% | 1,000 | 0.0% | 0.03% | -6.5% |
| Q4 2015 | $62,000 | – | 1,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |